Insulin glargine and lixisenatide Subcutaneous and Pertuzumab Intravenous
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Pertuzumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: pertuzumab
Brand name: Perjeta
Synonyms: Pertuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Pertzye
- Insulin glargine and lixisenatide Subcutaneous-Pexeva
- Insulin glargine and lixisenatide Subcutaneous-Pexidartinib
- Insulin glargine and lixisenatide Subcutaneous-Pexidartinib Hydrochloride
- Insulin glargine and lixisenatide Subcutaneous-Pfizerpen
- Insulin glargine and lixisenatide Subcutaneous-Pharaon Tea
- Pertuzumab Intravenous-Insulin glargine, recombinant Subcutaneous
- Pertuzumab Intravenous-Insulin glulisine
- Pertuzumab Intravenous-Insulin Glulisine (Cartridges and Pens)
- Pertuzumab Intravenous-Insulin Glulisine (Vials)
- Pertuzumab Intravenous-Insulin glulisine Subcutaneous
- Pertuzumab Intravenous-Insulin human inhaled Inhalation